violacein has been researched along with Malaria, Falciparum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanco, YC; Brocchi, M; Costa, FT; Duran, N; Facchini, G; Goelnitz, U; Justo, GZ; Lopes, SC; Nogueira, PA; Rodrigues, FL; Wunderlich, G | 1 |
| Baum, J; Freemont, PS; Lai, HE; Wilkinson, MD | 1 |
2 other study(ies) available for violacein and Malaria, Falciparum
| Article | Year |
|---|---|
Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.
Topics: Animals; Antimalarials; Chloroquine; Chromobacterium; Drug Resistance; Humans; Indoles; Malaria; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Parasitemia; Parasitic Sensitivity Tests; Plasmodium chabaudi; Plasmodium falciparum; Treatment Outcome | 2009 |
A Biosynthetic Platform for Antimalarial Drug Discovery.
Topics: Actin Cytoskeleton; Antimalarials; Artemisinins; Biosynthetic Pathways; Drug Discovery; Drug Resistance; Escherichia coli; High-Throughput Screening Assays; Humans; Indoles; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Synthetic Biology | 2020 |